Downregulation of putative tumor suppressor gene TSC-22 in human brain tumors

Journal of Surgical Oncology

Volumn 82, Issue 1, 2003, Pages 57-64

  Shostak, Katherina O ^a   Dmitrenko, Vladimir V ^a   Garifulin, Oleg M ^a   Rozumenko, Vladimir D ^b   Khomenko, Olexiy V ^b   Zozulya, Yuriy A ^b   Zehetner, Günther ^c   Kavsan, Vadym M ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b Institute of Neurosurgery Ams of Ukraine   (Ukraine)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Astrocytoma; Differential expression; Differential hybridization; Glioblastoma multiforme; High density cDNA filter arrays

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BRAIN TUMOR; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA LIBRARY; DNA SCREENING; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLIOBLASTOMA; GLIOSARCOMA; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALIGNANT MENINGIOMA; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA HYBRIDIZATION; TUMOR SUPPRESSOR GENE;

ADULT; BRAIN NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE LIBRARY; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0037219571     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10180     Document Type: Article

References (32)

1. Maier D, Zhang Z, Taylor E, et al.: Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Oncogene 1998;16:3331-3335.
2. Rosenberg EJ, Lisle DK, Burwick JA, et al.: Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene 1996;13:2483-2485.
3. Ino Y. Silver JS, Blazejewski L, et al.: Common regions of deletions on chromosome 22q12, 22q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. J Neuropathol Exp Neurol 1999;58:881-885.
4. Simons A, Jeuken JW, Eleweld MJ, et al.: Isolation and characterization of glioblastoma-associated homozygously deleted DNA fragments from chromosomal region 9p21 suggests involvement of multiple tumor suppressor genes. J Pathol 1999;189:402-409.
5. Smith JS, Tachibana I, Allen C, et al.: Cloning of a human ortholog (RPH3AL) of (RNO)Rph3al from a candidate 17p13.3 medulloblastoma tumor suppressor locus. Genomics 1999;59:97-101.
6. Farrell WE, Clayton RN: Tumor suppressor genes in pituitary tumor formation. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13:81-93.
7. Bello MJ, de Campos JM, Vaquero J, et al.: High-resolution analysis of chromosome arm lp alterations in meningioma. Cancer Genet Cytogenet 2000;20:30-36.
8. Shibanuma M, Kuroki T, Nose K: Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor beta l and other growth factors. J Biol Chem 1992;267:10219-10224.
9. Dmitrenko VV, Garifulin OM, Smikodub OI, et al.: Analysis of human genome expression by using of cDNA libraries of different tissues. Cytol Genet (Ukr) 1995;29:64-71.
10. Dmitrenko VV, Garifulin OM, Shostak KO, et al.: Characterization of different types of mRNAs expressing in human brain. Cytol Genet (Ukr) 1996;30:41-47.
11. Dmitrenko VV, Shostak KO, Garifulin OM, et al.: Changes of gene expression in human brain astrocytomas. Exp Oncol (Ukr) 1998;20:191-197.
12. Sambrook J, Fritch EF, Maniatis T: "Molecular Cloning: A Laboratory Manual." 2nd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
13. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
14. Rae FK, Stephenson SA, Nicol DL, Clements JA: Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int J Cancer 2000;88:726-732.
15. Sanger FS. Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:6463-6467.
16. Diatchenko L, Lukyanov S, Lau YF, et al.: Suppression subtractive hybridization: A versatile method for identifying differentially expressed genes. Methods Enzymol 1999;303:349-380.
17. Nguyen C, Rocha D, Granjeaud S. et al.: Differential gene expression in the murine thymus assayed by quantitative hybridization of arrayed cDNA clones. Genomics 1995;29:207-216.
18. Jay P, Ji JW, Marsollier C, et al.: Cloning of the human homologue of the TGFbeta-stimulated clone 22 gene. Biochem Biophys Res Commun 1996;222:821-826.
19. Ohta S, Shimekake Y, Nagata K: Molecular cloning and characterization of a transcription factor for the C-type natriuretic peptide gene promoter. Eur J Biochem 1996;242:460-466.
20. Dmitrenko VV, Kavsan VM: Variability of polyadenylation sites in mRNAs from human fetal liver. FEBS Lett 1991;280:284-286.
21. Kestler HA, van der Leebe B-JM, van der Saag PT, van der Burg B: Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J Biol Chem 1997;272:16637-16643.
22. Kestler HA, Blanchetot C, den Hertog J, et al.: Transforming growth factor beta stimulated clone TSC-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. J Biol Chem 1999;274:27439-27447.
23. Riechmann V, van Cruchten I. Sablitzky F: The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3. Nucleic Acids Res 1994;22:749-755.
24. Nakashiro K, Kawamata H, Hino S, et al.: Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Cancer Res 1998;58:549-555.
25. Ohta S, Yanagihara K, Nagata K: Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta. Biochem J 1997;324:777-782.
26. Kawamata H, Nakashiro K, Uchida D, et al.: Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. Br J Cancer 1998;77:71-78.
27. Henson JW, Schnitker BL, Correa KM, et al.: The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994;36:714-721.
28. Venkatraj VS, Begemann M, Sobrino A, et al.: Genomic changes in glioblastoma cell lines detected by comparative genomic hybridization. J Neurooncol 1998;36:141-148.
29. Harada K, Nishizaki T, Ozaki S, et al.: Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. Cancer Res 1998;58:4694-4700.
30. Huhn SL, Mohapatra G, Bollen A, et al.: Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: Correlation with radiation treatment outcome. Clin Cancer Res 1999;5:1435-1443.
31. Uchida D, Kawamata H, Omotehara F, et al.: Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line. Lab Invest 2000;80:955-963.
32. Omotehara F, Uchida D, Hino S, et al.: In vivo enhancement of chemosensitivity of human salivary gland cancer cells by overexpression of TGF-beta stimulated clone-22. Oncol Rep 2000;7:737-740.